πŸ‡ΊπŸ‡Έ FDA
Patent

US 10689456

Anti-CD70 chimeric antigen receptors

granted A61KA61K2239/38A61K2239/57

Quick answer

US patent 10689456 (Anti-CD70 chimeric antigen receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2239/38, A61K2239/57, A61K35/17, A61K40/11